These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30671448)

  • 21. Precision Medicine in Asthma-Using Phenotypes to Understand Endotypes That Lead Us to New Therapeutic Options.
    Fuhlbrigge AL; Castro M
    J Allergy Clin Immunol Pract; 2020 Feb; 8(2):496-497. PubMed ID: 32037110
    [No Abstract]   [Full Text] [Related]  

  • 22. [For real asthma control].
    Letonturier P
    Presse Med; 2007 Jan; 36(1 Pt 1):77-8. PubMed ID: 17285694
    [No Abstract]   [Full Text] [Related]  

  • 23. Unmet Needs in Severe Asthma Subtyping and Precision Medicine Trials. Bridging Clinical and Patient Perspectives.
    Siddiqui S; Denlinger LC; Fowler SJ; Akuthota P; Shaw DE; Heaney LG; Brown L; Castro M; Winders TA; Kraft M; Wagers S; Peters MC; Pavord ID; Walker S; Jarjour NN
    Am J Respir Crit Care Med; 2019 Apr; 199(7):823-829. PubMed ID: 30726120
    [No Abstract]   [Full Text] [Related]  

  • 24. Biomarkers and asthma management: analysis and potential applications.
    Richards LB; Neerincx AH; van Bragt JJMH; Sterk PJ; Bel EHD; Maitland-van der Zee AH
    Curr Opin Allergy Clin Immunol; 2018 Apr; 18(2):96-108. PubMed ID: 29389730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Going Beyond "Bio-markers," Think "Life-markers".
    Tan L; Chupp G; Castro M; Kraft M
    Chest; 2020 Mar; 157(3):503-505. PubMed ID: 32145809
    [No Abstract]   [Full Text] [Related]  

  • 26. How to Control Asthma with Personalized Management: Where Do We Stand Now?
    Wang M; Yao Y; Jiang S; Tao F; Tang R; Sun J
    Curr Drug Metab; 2018; 19(14):1188-1198. PubMed ID: 29380695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asthma phenotypes in children and stratified pharmacological treatment regimens.
    Iordanidou M; Loukides S; Paraskakis E
    Expert Rev Clin Pharmacol; 2017 Mar; 10(3):293-303. PubMed ID: 27936975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biologic and New Therapies in Asthma.
    Tabatabaian F; Ledford DK; Casale TB
    Immunol Allergy Clin North Am; 2017 May; 37(2):329-343. PubMed ID: 28366480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Many "Buckets" of Severe Asthma: Moving Toward Personalized Management.
    Moore WC; Castro M
    J Allergy Clin Immunol Pract; 2017; 5(4):936-937. PubMed ID: 28689844
    [No Abstract]   [Full Text] [Related]  

  • 30. Precision medicine in asthma: the role of bronchial thermoplasty.
    Oberle AJ; Mathur P
    Curr Opin Pulm Med; 2017 May; 23(3):254-260. PubMed ID: 28319473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Th1-related disease development during omalizumab treatment: Two cases with severe asthma.
    Hayashi H; Fukutomi Y; Mitsui C; Watai K; Tomita Y; Kamide Y; Sekiya K; Tsuburai T; Horita A; Saito I; Hasegawa Y; Taniguchi M
    Allergol Int; 2018 Jul; 67(3):405-407. PubMed ID: 29191372
    [No Abstract]   [Full Text] [Related]  

  • 32. Biomarkers for severe allergic asthma in children: could they be useful to guide disease control and use of omalizumab?
    Amat F; Labbé A
    Expert Rev Respir Med; 2018 Jun; 12(6):475-482. PubMed ID: 29741411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stability of Asthma Control Implies No Changes in microRNAs Expression.
    Rial MJ; Rodrigo Muñoz JM; Sastre B; Sastre J; Del Pozo V
    J Investig Allergol Clin Immunol; 2019; 29(5):388-389. PubMed ID: 31062689
    [No Abstract]   [Full Text] [Related]  

  • 34. Personalized medicine comes a step closer for asthma.
    Gottlieb S
    West J Med; 2000 Dec; 173(6):372-3. PubMed ID: 11112740
    [No Abstract]   [Full Text] [Related]  

  • 35. A Critical Evaluation of Anti-IL-13 and Anti-IL-4 Strategies in Severe Asthma.
    Bagnasco D; Ferrando M; Varricchi G; Passalacqua G; Canonica GW
    Int Arch Allergy Immunol; 2016; 170(2):122-31. PubMed ID: 27637004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Personalized medicine for patients with asthma.
    Greenberger PA
    J Allergy Clin Immunol; 2010 Feb; 125(2):305-6. PubMed ID: 20159238
    [No Abstract]   [Full Text] [Related]  

  • 37. Airway Inflammatory Biomarker: Could It Tailor the Right Medications for the Right Asthmatic Patient?
    Zedan MM; Osman AM; Laimon WN; Zedan MM; Abo-Elkheir NY; Zaki A
    Iran J Immunol; 2016 Jun; 13(2):70-88. PubMed ID: 27350629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of asthma endotypes: implications for therapy.
    Stokes JR; Casale TB
    Ann Allergy Asthma Immunol; 2016 Aug; 117(2):121-5. PubMed ID: 27499539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asthma phenotyping: noninvasive biomarkers suitable for bedside science are the next step to implement precision medicine.
    Dahlén SE
    J Intern Med; 2016 Feb; 279(2):205-7. PubMed ID: 26785954
    [No Abstract]   [Full Text] [Related]  

  • 40. Phenotypes/endotypes-driven treatment in asthma.
    Braido F; Tiotiu A; Kowal K; Mihaicuta S; Novakova P; Oguzulgen IK
    Curr Opin Allergy Clin Immunol; 2018 Jun; 18(3):184-189. PubMed ID: 29601354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.